Drug Profile
Cetuximab hyaluronic acid complex
Alternative Names: HA-cetuximabLatest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator Alchemia
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 07 Mar 2013 Suspended for Cancer in Australia (IV)
- 07 May 2010 Early research in Cancer in Australia (IV)